Article
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.
The Journal of antimicrobial chemotherapy - 1 Oct 2008
Crespo Manuel, Mira José A, Pineda Juan A, Van den Eynde Eva, Ríos-Villegas María J, Collado Antonio, Girón-González José A, López-Cortés Luis F, González-Serrano Mercedes, Rivero Antonio, Merino Dolores, Esteban Juan I
Abstract excerpt
BACKGROUND: Combination of pegylated interferon (Peg-IFN) and ribavirin is the standard treatment for HCV infection in HIV co-infected patients. However, data available on the efficacy of this therapy in co-infected patients who failed a former interferon-based regimen are limited. METHODS: We analysed the efficacy and safety of the Peg-IFN alfa-2a or alfa-2b plus ribavirin combination in a multicentre...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
